Authors:
HINDERLITER AL
WILLIS PW
BARST RJ
RICH S
RUBIN LJ
BADESCH DB
GROVES BM
MCGOON MD
TAPSON VF
BOURGE RC
BRUNDAGE BH
KOERNER SK
LANGLEBEN D
KELLER CA
MURALI S
URETSKY BF
KOCH G
LI S
CLAYTON LM
JOBSIS MM
BLACKBURN SD
CROW JW
LONG WA
Citation: Al. Hinderliter et al., EFFECTS OF LONG-TERM INFUSION OF PROSTACYCLIN (EPOPROSTENOL) ON ECHOCARDIOGRAPHIC MEASURES OF RIGHT-VENTRICULAR STRUCTURE AND FUNCTION IN PRIMARY PULMONARY-HYPERTENSION, Circulation, 95(6), 1997, pp. 1479-1486
Authors:
BARST RJ
RUBIN LJ
LONG WA
MCGOON MD
RICH S
BADESCH DB
GROVES BM
TAPSON VF
BOURGE RC
BRUNDAGE BH
KOERNER SK
LANGLEBEN D
KELLER CA
MURALI S
URETSKY BF
CLAYTON LM
JOBSIS MM
BLACKBURN SD
SHORTINO D
CROW JW
Citation: Rj. Barst et al., A COMPARISON OF CONTINUOUS INTRAVENOUS EPOPROSTENOL (PROSTACYCLIN) WITH CONVENTIONAL THERAPY FOR PRIMARY PULMONARY-HYPERTENSION, The New England journal of medicine, 334(5), 1996, pp. 296-301
Authors:
BARST RJ
KERSTEIN D
KIRKPATRICK J
BLACKBURN SD
LEVY PS
Citation: Rj. Barst et al., LONG-TERM CONTINUOUS INTRAVENOUS PROSTACYCLIN IMPROVES SURVIVAL IN CHILDREN WITH PRIMARY PULMONARY-HYPERTENSION, Circulation, 92(8), 1995, pp. 593-593